CHRONIC NEUROPATHIC PAIN IN POST COVID PATIENTS RELATION WITH DISEASE SEVERITY

NUS AWAN; A ISHAQ; M NAZIR; L KHALID; MM IQBAL; ZM MUGHAL

doi:10.54112/bcsrj.v2024i1.1134

Authors

NUS AWAN Department of Medicine SKBZ/CMH hospital Muzaffarabad, Pakistan
A ISHAQ Department of Neurology Polyclinic hospital Islamabad, Pakistan
M NAZIR Department of Medicine SKBZ/CMH hospital Muzaffarabad, Pakistan
L KHALID Department of Surgery SKBZ/CMH hospital Muzaffarabad, Pakistan
MM IQBAL Mater Misericordiae University Hospital, dublin, Ireland
ZM MUGHAL Department of Pulmonology SKBZ/CMH hospital Muzaffarabad, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2024i1.1134

Keywords:

Post COVID, Neuropathic Pain, Disease Severity, Long COVID

Abstract

Post-COVID syndrome, also known as post-acute sequelae of SARS-CoV-2 infection, has been associated with various long-term effects, one of which is neuropathic pain. This condition is characterized by chronic pain arising from nerve injury and has been observed in many patients recovering from COVID-19, potentially correlating with the severity of the initial infection. Objective: The study aimed to compare the prevalence and types of neuropathic pain in post-COVID patients and investigate the correlation between chronic neuropathic pain and the severity of the initial COVID-19 infection. Methods: This prospective observational study was conducted at the Department of Medicine, SKBZ/CMH Hospital Muzaffarabad, AJK, from February to August 2024. One hundred fifty post-COVID patients were enrolled, categorized into mild/moderate and severe groups (50 patients each). Neuropathic pain was assessed using the Neuropathic Pain Scale (NPS) at three and six months post-infection. Statistical analysis was performed using Analysis of Variance (ANOVA) to compare mean responses, with p-values < 0.05 considered statistically significant. Results: Out of 150 patients, 53.3% (80 patients) reported experiencing chronic neuropathic pain. Neuropathic pain was more prevalent in patients who had severe COVID-19 symptoms, with 65% of severe cases reporting pain, compared to 40% of mild/moderate cases. The mean NPS score was significantly higher in severe cases (6.8 ± 1.2) compared to mild/moderate cases (4.3 ± 1.0), with a p-value of < 0.01, indicating a strong association between the severity of the initial infection and the subsequent development of neuropathic pain. Conclusion: There is a higher incidence and severity of chronic neuropathic pain in post-COVID patients, particularly those who experienced severe disease manifestations. Early identification and targeted pain management strategies are essential for mitigating the long-term impact of neuropathic pain in these patients.

Downloads

Download data is not yet available.

References

Theoharides TC, Kempuraj D. Role of SARS-CoV-2 spike-protein-induced activation of microglia and mast cells in the pathogenesis of neuro-COVID. Cells. 2023;12(5):688.

Zeraatkar D, Ling M, Kirsh S, Jassal T, Pitre T, Chakraborty S, et al. Interventions for the management of post COVID-19 condition (long COVID): Protocol for a living systematic review & network meta-analysis. medRxiv. 2024:2024.03. 15.24304168.

Javed S, Hung J, Huh BK. Impact of COVID-19 on chronic pain patients: a pain physician’s perspective. Taylor & Francis; 2020. p. 275-7.

McFarland AJ, Yousuf MS, Shiers S, Price TJ. Neurobiology of SARS-CoV-2 interactions with the peripheral nervous system: implications for COVID-19 and pain. Pain reports. 2021;6(1):e885.

Frere JJ, Serafini RA, Pryce KD, Golynker I, Panis M, Zimering J, et al. A Molecular Basis of Long COVID-19. 2021.

Lo Bianco G, Papa A, Schatman ME, Tinnirello A, Terranova G, Leoni MLG, et al. Practical advices for treating chronic pain in the time of COVID-19: a narrative review focusing on interventional techniques. Journal of Clinical Medicine. 2021;10(11):2303.

Pang Z, Tang A, He Y, Fan J, Yang Q, Tong Y, et al. Neurological complications caused by SARS-CoV-2. Clinical Microbiology Reviews. 2024:e00131-24.

Sarpal DK, Argyelan M, Robinson DG, Szeszko PR, Karlsgodt KH, John M, et al. Baseline striatal functional connectivity as a predictor of response to antipsychotic drug treatment. American Journal of Psychiatry. 2016;173(1):69-77.

Horlenko O, Chuhran Y, Prylypko L, Kossey G, Pushkarenko O, Sochka N, et al. E-Poster Viewing-Neonatology AS02-15. Infectious diseases. Markers of inflammatory response in infants with intrauterine infection from mothers with identified torch infection. 2022.

Picone P, Sanfilippo T, Guggino R, Scalisi L, Monastero R, Baschi R, et al. Neurological consequences, mental health, physical care, and appropriate nutrition in long-COVID-19. Cellular and Molecular Neurobiology. 2023;43(5):1685-95.

Vrettou CS, Mantziou V, Vassiliou AG, Orfanos SE, Kotanidou A, Dimopoulou I. Post-intensive care syndrome in survivors from critical illness including COVID-19 patients: a narrative review. Life. 2022;12(1):107.

Jason LA, Islam MF. A classification system for post-acute sequelae of SARS CoV-2 infection. Central Asian Journal of Medical Hypotheses and Ethics. 2022;3(1):38-51.

Chowdhury MMH, Fontaine M-N, Lord S-E, Quenum AJI, Limoges M-A, Rioux-Perreault C, et al. Impact of a tailored exercise regimen on physical capacity, systemic oxidative stress and plasma proteomic profile in PCC patients. 2023.

Dos Santos PK, Sigoli E, Bragança LJ, Cornachione AS. The musculoskeletal involvement after mild to moderate COVID-19 infection. Frontiers in Physiology. 2022;13:813924.

Maurer C, Exl MT, Gander H-P, Bertschi D, Fischbacher I, Barbezat I, et al. Consequences of a stay in the intensive care unit and outpatient follow-up care for chronic critically ill patients: A retrospective data analysis. Australian Critical Care. 2024.

E Carey G, Bromfield N, O'Reilly R, Thampapillai D. The Australian COVID-19 vaccine claims scheme: A case of administrative burden and exclusion. Nicholas and O'Reilly, Rachel and Thampapillai, Dilan, The Australian COVID-19 Vaccine Claims Scheme: A Case of Administrative Burden and Exclusion (August 10, 2024). 2024.

Attal N, Bouhassira D, Colvin L. Advances and challenges in neuropathic pain: a narrative review and future directions. British Journal of Anaesthesia. 2023;131(1):79-92.

Singh SJ, Daynes E, McAuley HJ, Raman B, Greening NJ, Chalder T, et al. Balancing the value and risk of exercise-based therapy post-COVID-19: a narrative review. European Respiratory Review. 2023;32(170).

Feldman DE, Boudrias M-H, Mazer B. Long COVID symptoms in a population-based sample of persons discharged home from hospital. Canadian Journal of Public Health. 2022;113(6):930-9.